Ryan Specialty Holdings Inc. (NYSE:RYAN - Free Report) - Equities researchers at William Blair boosted their Q1 2026 earnings estimates for shares of Ryan Specialty in a note issued to investors on Friday, August 1st. William Blair analyst A. Klauber now anticipates that the company will post earnings per share of $0.51 for the quarter, up from their previous estimate of $0.50. The consensus estimate for Ryan Specialty's current full-year earnings is $2.29 per share.
Ryan Specialty (NYSE:RYAN - Get Free Report) last issued its earnings results on Thursday, July 31st. The company reported $0.66 earnings per share for the quarter, meeting the consensus estimate of $0.66. The business had revenue of $855.17 million for the quarter, compared to the consensus estimate of $837.52 million. Ryan Specialty had a net margin of 6.81% and a return on equity of 48.70%. The business's quarterly revenue was up 23.0% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.58 earnings per share.
RYAN has been the topic of several other research reports. Wall Street Zen raised shares of Ryan Specialty from a "sell" rating to a "hold" rating in a report on Sunday. The Goldman Sachs Group raised shares of Ryan Specialty from a "neutral" rating to a "buy" rating and lifted their target price for the company from $74.00 to $81.00 in a report on Tuesday, May 13th. Barclays lowered their target price on shares of Ryan Specialty from $83.00 to $79.00 and set an "overweight" rating on the stock in a report on Monday, July 7th. Keefe, Bruyette & Woods decreased their price objective on shares of Ryan Specialty from $76.00 to $75.00 and set an "outperform" rating on the stock in a report on Wednesday, April 9th. Finally, Wells Fargo & Company decreased their price objective on shares of Ryan Specialty from $63.00 to $60.00 and set an "equal weight" rating on the stock in a report on Friday. Three equities research analysts have rated the stock with a hold rating and eight have given a buy rating to the company. According to data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and a consensus price target of $77.70.
Read Our Latest Stock Report on Ryan Specialty
Ryan Specialty Stock Down 5.3%
Shares of NYSE:RYAN opened at $57.97 on Monday. The company has a market cap of $15.21 billion, a price-to-earnings ratio of 165.63, a PEG ratio of 1.57 and a beta of 0.64. The firm's 50-day simple moving average is $66.47 and its 200-day simple moving average is $68.22. The company has a quick ratio of 1.05, a current ratio of 1.01 and a debt-to-equity ratio of 2.88. Ryan Specialty has a fifty-two week low of $55.77 and a fifty-two week high of $77.16.
Ryan Specialty Announces Dividend
The firm also recently announced a quarterly dividend, which will be paid on Tuesday, August 26th. Shareholders of record on Tuesday, August 12th will be given a dividend of $0.12 per share. The ex-dividend date is Tuesday, August 12th. This represents a $0.48 dividend on an annualized basis and a yield of 0.8%. Ryan Specialty's payout ratio is presently 137.14%.
Insider Transactions at Ryan Specialty
In other Ryan Specialty news, EVP Mark Stephen Katz sold 14,377 shares of Ryan Specialty stock in a transaction dated Friday, June 13th. The shares were sold at an average price of $65.84, for a total transaction of $946,581.68. Following the completion of the transaction, the executive vice president owned 1,117 shares in the company, valued at approximately $73,543.28. The trade was a 92.79% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Director David P. Bolger sold 5,000 shares of Ryan Specialty stock in a transaction dated Tuesday, June 3rd. The stock was sold at an average price of $70.80, for a total transaction of $354,000.00. Following the transaction, the director owned 71,467 shares of the company's stock, valued at approximately $5,059,863.60. The trade was a 6.54% decrease in their position. The disclosure for this sale can be found here. Insiders own 52.21% of the company's stock.
Hedge Funds Weigh In On Ryan Specialty
A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Whittier Trust Co. of Nevada Inc. raised its position in shares of Ryan Specialty by 281.6% in the first quarter. Whittier Trust Co. of Nevada Inc. now owns 332 shares of the company's stock valued at $25,000 after buying an additional 245 shares during the last quarter. SVB Wealth LLC acquired a new position in shares of Ryan Specialty in the first quarter valued at approximately $26,000. WPG Advisers LLC acquired a new position in shares of Ryan Specialty in the first quarter valued at approximately $32,000. Central Pacific Bank Trust Division acquired a new position in shares of Ryan Specialty in the second quarter valued at approximately $31,000. Finally, Golden State Wealth Management LLC acquired a new position in shares of Ryan Specialty in the first quarter valued at approximately $35,000. Institutional investors and hedge funds own 84.82% of the company's stock.
About Ryan Specialty
(
Get Free Report)
Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.
Recommended Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Ryan Specialty, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ryan Specialty wasn't on the list.
While Ryan Specialty currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.